Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andre Bosly
Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20+Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation in the Rituximab Era
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Rituximab and Autologous Stem-Cell Transplantation for High-Risk Diffuse Large B-Cell Lymphoma – Authors' Reply
The Lancet Oncology
Oncology
Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma
American Journal of Hematology
Hematology
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Direct Costs Associated With Relapsed Diffuse Large B‐Cell Lymphoma Therapies
Oncologist
Cancer Research
Medicine
Oncology
Intravenous Immunoglobulin Therapy Use in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated With Tisagenlecleucel in the Juliet Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma With Residual Extranodal Involvement
Korean Journal of Internal Medicine
Internal Medicine
Long-Term Efficacy and Safety of Lenalidomide Maintenance in Patients With Relapsed Diffuse Large B-Cell Lymphoma Who Are Not Eligible for Autologous Transplantation (Asct)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
